SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination - ScienceDirect
Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination | Science Advances
Immunity to SARS‐CoV‐2 induced by infection or vaccination - Castro Dopico - 2022 - Journal of Internal Medicine - Wiley Online Library
The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion | Nature Communications
A functional assay for serum detection of antibodies against SARS‐CoV‐2 nucleoprotein | The EMBO Journal
Frontiers | Immune Evasive Effects of SARS-CoV-2 Variants to COVID-19 Emergency Used Vaccines
Antibody evasion by the P.1 strain of SARS-CoV-2
Harnais Chat Anti évasion,Laisse Chat,Colliers,Harnais et Laisses pour Chats,Harnais Chaton Réglable,Laisse pour Chat,Harnais pour Chat Petit Chien Lapin（2 Pièces） : Amazon.fr: Animalerie
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion | Nature
Viruses | Free Full-Text | Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants | HTML
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement | bioRxiv
Therapeutic Vaccines for Cancer Immunotherapy | ACS Biomaterials Science & Engineering
Epidemiological characteristics of the B.1.526 SARS-CoV-2 variant | Science Advances
Analysis of a SARS-CoV-2 convalescent cohort identified a common strategy for escape of vaccine-induced anti-RBD antibodies by Beta and Omicron variants - eBioMedicine
A functional assay for serum detection of antibodies against SARS‐CoV‐2 nucleoprotein | The EMBO Journal
The anti–SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination | Science Translational Medicine
IJMS | Free Full-Text | Targeting the Sphingolipid Rheostat in Gliomas | HTML
The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants - ScienceDirect
SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development - Ao - 2022 - MedComm - Wiley Online Library
Vaccines | Free Full-Text | Post-Immune Antibodies in HIV-1 Infection in the Context of Vaccine Development: A Variety of Biological Functions and Catalytic Activities | HTML
Frontiers | SARS-CoV-2 Variants, Vaccines, and Host Immunity
Frontiers | Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
Vaccines for established cancer: overcoming the challenges posed by immune evasion | Nature Reviews Cancer
Antibody evasion by the P.1 strain of SARS-CoV-2 - ScienceDirect
Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2
Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages - ScienceDirect
Control of host PTMs by intracellular bacteria: An opportunity toward novel anti-infective agents - ScienceDirect
Structural and biochemical mechanism for increased infectivity and immune evasion of Omicron BA.2 variant compared to BA.1 and their possible mouse origins | Cell Research
A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine | mBio
